CLEAN : Covid-19: Washington, DC, residents react to Moderna vaccine announcement

The speaker expresses concerns about the rapid development and approval of a vaccine, emphasizing the need for thorough testing and trials to ensure its effectiveness and safety. They discuss the removal of bureaucratic red tape to speed up the process but remain skeptical about the vaccine's safety. The speaker shares their personal decision to wait before taking a fast-tracked vaccine, citing their previous experience with coronavirus and a preference to observe the vaccine's effects on others first.

What is the speaker's main concern about the early release of a vaccine?

• It will not be available to everyone.

• It might cause more side effects.

• It might be too expensive.

• It could be less effective and risk more lives.

What does the speaker attribute the rapid development of the vaccine to?

• Advanced technology in vaccine production.

• Removal of bureaucratic red tape.

• Increased funding for research.

• Global collaboration among scientists.

Why does the speaker prefer not to take a fast-tracked vaccine?

• They are allergic to vaccines.

• They want to see its effects on others first.

• They think it will be ineffective.

• They believe it will be too costly.

What personal experience does the speaker share about COVID-19?

• They have never contracted the virus.

• They had a mild case at the pandemic's start.

• They have been vaccinated already.

• They were hospitalized due to severe symptoms.

How long does the speaker plan to wait before considering vaccination?

• They do not plan to get vaccinated.

• Until the end of the pandemic.

• A year or two.

• A few months.